Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Nemaura Medical stock | $4.35

Own Nemaura Medical stock in just a few minutes.

Fact checked

Nemaura Medical Inc is a medical devices business based in the US. Nemaura Medical shares (NMRD) are listed on the NASDAQ and all prices are listed in US Dollars. Nemaura Medical employs 17 staff and has a market cap (total outstanding shares value) of USD$85.9 million.

How to buy shares in Nemaura Medical

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Nemaura Medical. Find the stock by name or ticker symbol: NMRD. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Nemaura Medical reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$4.35, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Nemaura Medical, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Nemaura Medical. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Nemaura Medical share price

Use our graph to track the performance of NMRD stocks over time.

Nemaura Medical shares at a glance

Information last updated 2020-10-20.
Latest market closeUSD$4.35
52-week rangeUSD$0.53 - USD$16.5
50-day moving average USD$3.8249
200-day moving average USD$6.2312
Wall St. target priceUSD$14
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.024

Buy Nemaura Medical shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
$0 for US stocks
Stocks, Options, ETFs
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Nemaura Medical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Nemaura Medical price performance over time

Historical closes compared with the close of $4.35 from 2020-12-18

1 week (2021-01-13) -4.81%
1 month (2020-12-18) 4.35
3 months (2020-10-20) 16.00%
6 months (2020-07-20) -56.46%
1 year (2020-01-17) 20.76%
2 years (2019-01-18) 322.33%
3 years (2018-01-19) 4.8
5 years (2016-01-16) N/A

Nemaura Medical financials

Gross profit TTM USD$0
Return on assets TTM -42.99%
Return on equity TTM -245.29%
Profit margin 0%
Book value $0.092
Market capitalisation USD$85.9 million

TTM: trailing 12 months

Shorting Nemaura Medical shares

There are currently 99,007 Nemaura Medical shares held short by investors – that's known as Nemaura Medical's "short interest". This figure is 11.1% up from 89,117 last month.

There are a few different ways that this level of interest in shorting Nemaura Medical shares can be evaluated.

Nemaura Medical's "short interest ratio" (SIR)

Nemaura Medical's "short interest ratio" (SIR) is the quantity of Nemaura Medical shares currently shorted divided by the average quantity of Nemaura Medical shares traded daily (recently around 62662.658227848). Nemaura Medical's SIR currently stands at 1.58. In other words for every 100,000 Nemaura Medical shares traded daily on the market, roughly 1580 shares are currently held short.

However Nemaura Medical's short interest can also be evaluated against the total number of Nemaura Medical shares, or, against the total number of tradable Nemaura Medical shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Nemaura Medical's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Nemaura Medical shares in existence, roughly 0 shares are currently held short) or 0.0113% of the tradable shares (for every 100,000 tradable Nemaura Medical shares, roughly 11 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Nemaura Medical.

Find out more about how you can short Nemaura Medical stock.

Nemaura Medical share dividends

We're not expecting Nemaura Medical to pay a dividend over the next 12 months.

Have Nemaura Medical's shares ever split?

Nemaura Medical's shares were split on a 1:10 basis on 5 December 2019. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Nemaura Medical shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Nemaura Medical shares which in turn could have impacted Nemaura Medical's share price.

Nemaura Medical share price volatility

Over the last 12 months, Nemaura Medical's shares have ranged in value from as little as $0.53 up to $16.5. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Nemaura Medical's is -0.4584. This would suggest that Nemaura Medical's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Nemaura Medical has bucked the trend.

Nemaura Medical overview

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. The company provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site